BIOVENTUS
Bioventus is a global leader of active orthopaedic healing, providing clinically proven and cost-effective therapies and diagnostics that help patients regain active lifestyles. Bioventus' products are known for their innovation, safety and effectiveness. The company is the recognized leader in bone stimulation devices and among the leading distributors of osteoarthritis joint fluid therapies. Key products include: - EXOGEN(r) Ultrasound Bone Healing System - SUPARTZ(r) Joint ... Fluid Therapy (US only) - DUROLANE(r) Hyaluronic Acid, Single Injection (Outside US only) Bioventus' adherence to high quality standards, commitment to evidence-based medicine and strong ethical behavior makes the company a trusted partner for thousands of physicians worldwide. Bioventus employs 500 people and generates about $240 million in yearly revenue. The company is headquartered in Durham, N.C. Prior to launch in 2012, Bioventus was operating as the Biologics Division of Smith & Nephew.
BIOVENTUS
Industry:
Health Care Health Diagnostics Medical Device
Founded:
2012-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.bioventus.com
Total Employee:
251+
Status:
Active
Contact:
(919) 474-6700
Email Addresses:
[email protected]
Total Funding:
545 M USD
Technology used in webpage:
SPF Google Tag Manager Mobile Non Scaleable Content Microsoft Exchange Online Amazon Office 365 Mail IPv6 Google Maps Microsoft Azure DNS Google Maps API
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Push Doctor
Push Doctor is creating the future of healthcare.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-08-30 | CartiHeal | CartiHeal acquired by Bioventus | 315 M USD |
2021-07-29 | Misonix | Misonix acquired by Bioventus | 518 M USD |
2021-03-30 | Bioness | Bioness acquired by Bioventus | 45 M USD |
2015-11-30 | BioStructures | BioStructures acquired by Bioventus | N/A |
Investors List
Ampersand Capital Partners
Ampersand Capital Partners investment in Venture Round - Bioventus
Alcentra Capital Corporation
Alcentra Capital Corporation investment in Debt Financing - Bioventus
Pantheon Ventures
Pantheon Ventures investment in Venture Round - Bioventus
Spindletop Capital Management
Spindletop Capital Management investment in Venture Round - Bioventus
Alta Partners
Alta Partners investment in Venture Round - Bioventus
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Venture Round - Bioventus
Ampersand Capital Partners
Ampersand Capital Partners investment in Venture Round - Bioventus
White Pine Medical
White Pine Medical investment in Venture Round - Bioventus
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-08-25 | Trice Medical | Bioventus investment in Series D - Trice Medical | 27.55 M USD |
2021-06-24 | Vaporox | Bioventus investment in Corporate Round - Vaporox | 4.93 M USD |
2020-07-16 | CartiHeal | Bioventus investment in Corporate Round - CartiHeal | 15 M USD |
2018-02-01 | CartiHeal | Bioventus investment in Corporate Round - CartiHeal | 2.5 M USD |
Key Employee Changes
Date | New article |
---|---|
2022-02-28 | Bioventus Appoints Mark Singleton as Chief Financial Officer |
2021-11-01 | Sharon Klugewicz Joins Bioventus as Senior Vice President, Quality and Regulatory Affairs |
2020-03-26 | Bioventus names new CEO |
Official Site Inspections
http://www.bioventus.com Semrush global rank: 1.33 M Semrush visits lastest month: 21.9 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago